No Data
No Data
Earnings Week Ahead: Nike, Carnival, Constellation Brands, and More
Earnings Preview: ANGO to Report Financial Results Pre-market on October 03
AngioDynamics Initiates Thrombectomy System Trial Across Europe
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14
Express News | HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target
AngioDynamics Analyst Ratings